For In Vitro Diagnostic Use
Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing liquid biopsy assays that have been cleared or approved for use with samples collected in the Cell-Free DNA BCT device.
Performance characteristics of this device have only been established on the Guardant360® CDx assay.
Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing liquid biopsy assays that have been cleared or approved for use with samples collected in the Cell-Free DNA BCT device.
Looking for an older document? Click here for archived assays and certificates.
| Description | Catalog Number |
|---|---|
| 10.0 mL tube – 16 x 100 mm | |
| 6-tube pack glass | 230469 |
| 100-tube box glass | 230470 |
| 1000-tube case glass | 230471 |
New customers
Existing customers
International customers find a distributor
Streck’s patented portfolio of stabilization solutions enables scientists to mitigate and limit pre-analytical variation in critical samples, ease handling concerns and allow for room temperature storage, cold chain-free shipping and batch processing. Our direct draw blood collection tubes and preservation products for biofluids are recognized worldwide. Target analytes include cell-free DNA, cell-free RNA, clusters of differentiation antigens, extracellular vesicles and cellular nucleic acids.
